PYC is a serial ocular exon skipper now, how do you value a company/technology platform with scientific proof that it can seemingly remediate any target at will?
Excerpt from today’s announcement on its 2nd defined lead:
PYC is now progressing this candidate into human trials
Coupled with the safety/tolerability, pharmacokinetic and pharmacodynamic data generated in the animal models to date, this represents a compelling non-clinical data pack and PYC will now initiate the high purity manufacturing run required to support formal toxicological assessment and subsequently human studies of PYC-001.
PYC anticipates filing an Investigational New Drug application in support of its ADOA program in 1H 2024 prior to initiation of first in human studies.
PYC Price at posting:
7.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)